Search results
29 lut 2024 · In healthy individuals, the pericardial cavity contains 15 to 50 mL of an ultrafiltrate of plasma. Diseases of the pericardium present clinically in one of several ways: Acute and recurrent pericarditis. Pericardial effusion without major hemodynamic compromise. Cardiac tamponade.
- Colchicine
Patients must speak with a health care provider for complete...
- ESC
ESC - Acute pericarditis: Treatment and prognosis - UpToDate
- Melendo-Viu M, Marchán-Lopez Á, Guarch Cj, Et Al. a Systematic Review and Meta-Analysis of Randomized Controlled Trials Evaluating Pharmacologic Therapies for Acute and Recurrent Pericarditis. Trends Cardiovasc Med 2023; 33:319
A systematic review and meta-analysis of randomized...
- Medline
A total of 120 patients (mean age 56.9+/-18.8 years, 54...
- Results of the CORE
Results of the CORE - Acute pericarditis: Treatment and...
- EAPC
In 2005, The European Society of Cardiology (ESC) published...
- Hagerstown
Aetiological diagnosis in acute and recurrent pericarditis:...
- Treatment and Prognosis
A total of 120 patients (mean age 56.9+/-18.8 years, 54...
- Colchicine
14 lut 2023 · - ECG features of acute pericarditis versus acute MI - Indications for invasive workup in acute pericarditis - Diagnostic criteria for acute pericarditis and myopericarditis
18 kwi 2022 · General approach to treatment — In the treatment of acute pericarditis, the goals of therapy are the relief of pain, resolution of inflammation (and, if present, pericardial effusion), and the prevention of recurrence.
Prompt diagnosis and appropriate treatment of acute pericarditis may reduce the risk of acute complications and recurrences. New therapies, such as IL-1 blockers, show promising results in patients with recurrent/refractory pericarditis.
7 sty 2020 · The mainstay of treatment of pericarditis is represented by anti-inflammatory drugs. Anti-inflammatory treatments vary, however, in both effectiveness and side-effect profile. The objective of this review is to summarize the up-to-date management of acute and recurrent pericarditis.
7 sty 2020 · Acute pericarditis should be treated with a nonsteroidal anti-inflammatory drug (NSAID), typically with a 2- to 4-week taper after the resolution of symptoms. In addition, a 3-month course of colchicine (with weight-adjusted dosing) is recommended to reduce the risk of recurrent pericarditis.
The mainstay of treatment of pericarditis is represented by anti-inflammatory drugs. Anti-inflammatory treatments vary, however, in both effectiveness and side-effect profile. The objective of this review is to summarize the up-to-date management of acute and recurrent pericarditis.
